Business »  Topic »  Sanofi, GlaxoSmithKline in talks with EU to secure Covid-19 vaccine deal

Sanofi, GlaxoSmithKline in talks with EU to secure Covid-19 vaccine deal


The companies said the doses would be manufactured in European countries including France, Belgium, Germany and Italy

Sanofi is working on two vaccine projects including one in partnership with GlaxoSmithKline

Sanofi SA and GlaxoSmithKline Plc on Friday said they are in advanced discussions to supply up to 300 million doses of an experimental Covid-19 vaccine for the 27-country European Union.

Armed with an emergency fund of more than 2 billion euros (£1.80 billion), the European Commission wants to strike deals with up to six drugmakers for their vaccines for their 450 million citizens against the coronavirus that has killed ...


Read the full text business-standard